• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B-HCG II REAGENT PACK; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B-HCG II REAGENT PACK; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6802220
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/18/2014
Event Type  malfunction  
Event Description
The customer obtained discordant but reproducible vitros total b-hcg ii results from a patient sample tested undiluted and diluted (10 fold) on a vitros 5600 integrated system.Vitros b-hcg undiluted = 1644, 1651 vs.Diluted 10x = 7983, 8495 miu/ml.Ortho clinical diagnostics conservatively considers the expected vitros total b-hcg ii results for the patient sample to be the diluted values based on similar hcg results obtained using a non-vitros method.Biased results of the magnitude and direction observed may lead to inappropriate physician action if the results were to recur undetected.The vitros total b-hcg ii results were not reported from the laboratory.There was no allegation of patient harm as a result of this event.(b)(4).
 
Manufacturer Narrative
The investigation determined that discordant but reproducible vitros total b-hcg ii test results were obtained from a patient sample tested undiluted and diluted (10 fold) on a vitros 5600 integrated system.It is conservatively concluded that the vitros total b-hcg ii results obtained from the diluted sample are the expected hcg results based on a comparable hcg result obtained using a non-vitros method; however, this was not confirmed.There was no indication that a reagent issue contributed to the event.The root cause of this event is unknown.However, an instrument related issue or an unknown sample related event cannot be ruled out as potential contributing factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TOTAL B-HCG II REAGENT PACK
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key4013123
MDR Text Key21493158
Report Number3007111389-2014-00182
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 08/15/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/22/2015
Device Catalogue Number6802220
Device Lot Number1100
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 07/18/2014
Initial Date FDA Received08/15/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/03/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-